Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan as Adjuvant to Bevacizumab for DME
NCT02663141Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2015
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of losartan in diabetic macular edema (DME), sponsored by Tehran University of Medical Sciences. Started Jun 2015; status: completed.
02
Drugs
losartan
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT02663141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02663141.